Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre

Valentina Alice Rossi1,2, Matteo Palazzini3, Enrico Ammirati3,4

  • 1Department of Cardiology, University Hospital Zurich, Zurich, Switzerland ardansaguner@gmail.com valereds@gmail.com.

PubMed

Insights

Cardiac sarcoidosis (CS) and arrhythmogenic cardiomyopathy (ACM) genetic variants coexist, presenting unique symptoms like AV block and PR prolongation. Early evaluation is crucial for patients with ACM variants showing conduction issues or septal involvement.

Area of Science:

  • Cardiology
  • Genetics
  • Immunology

Background:

  • Cardiac sarcoidosis (CS) is an inflammatory heart condition; arrhythmogenic cardiomyopathy (ACM) is a genetic disorder affecting desmosomal proteins.
  • The interplay between CS and ACM genetic variants presents diagnostic and management challenges.
  • This study investigates the clinical, imaging, and genetic profiles of patients with coexisting CS and ACM-associated genetic variants.

Purpose of the Study:

  • To characterize the clinical, imaging, and genetic features of patients with coexisting cardiac sarcoidosis and ACM-associated genetic variants.
  • To identify distinct patterns associated with the coexistence of these conditions.

Main Methods:

  • A multicentre retrospective case-control study.
  • Involved three groups: CS with ACM variants (n=5), ACM variants without CS (n=5), and CS without variants (n=5).
  • Analyzed clinical symptoms, ECG, echocardiography, cardiac MRI, and PET imaging data.

Main Results:

  • Patients with CS and ACM variants showed higher rates of atrioventricular block (100%), PR prolongation (204 ms), and atrial fibrillation (80%) compared to those with ACM variants alone.
  • Septal involvement was more prevalent in patients with both conditions (80%) versus ACM variants alone (20%).
  • Identified genetic variants included PKP2, DSG2, DSP, and TTN.

Conclusions:

  • Coexistence of CS and ACM genetic variants is linked to specific clinical features: PR prolongation, AV block, septal involvement, and atrial fibrillation.
  • Suggests evaluating for CS in individuals with ACM genetic variants presenting with conduction abnormalities or septal involvement.
  • Highlights the need for tailored diagnostic and therapeutic strategies for these complex cases.
Abstract